Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice

Vaccine

Volumn 25, Issue 11, 2007, Pages 2103-2111

  Sharma, Sharad Kumar ^a   Gupta, Chittarmal ^b   Dwivedi, Varun ^a   Misra Bhattacharya, Shailja ^b   Mohammad, Owais ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Drug resistance; Integral proteins; Liposomes; Malaria; Membrane protein

Indexed keywords

CHLOROQUINE; CHOLESTEROL; FREUND ADJUVANT; IMMUNOGLOBULIN G; LIPOSOME; MEFLOQUINE; MEMBRANE PROTEIN; PHOSPHATE BUFFERED SALINE; PHOSPHATIDYLCHOLINE; POLYCLONAL ANTIBODY; PROTOZOAL PROTEIN; PYRIMETHAMINE; QUININE; SEPHAROSE; SULFADOXINE; TRITON X 114;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MALARIA; MEROZOITE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; PROVOCATION TEST; SCHIZONT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, PROTOZOAN; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOBLOTTING; LIPOSOMES; MALARIA; MALARIA VACCINES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR WEIGHT; PARASITEMIA; PLASMODIUM YOELII; PROTOZOAN PROTEINS; SURVIVAL ANALYSIS;

EID: 33846893424     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.11.023     Document Type: Article

References (45)

1. Theisen M., Soe S., Oeuvray C., Thomas A.W., Vuust J., Danielsen S., et al. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun 66 (1998) 11-17
2. Kappe S.H.I., Noe A.R., Fraser T.S., Blair P.L., and Adams J.H. A family of chimeric erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA 95 (1998) 1230-1235
3. Burns Jr. J.M., Daly T.M., Vaidya A.B., and Long C.A. The 39 portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody. Proc Natl Acad Sci USA 85 (1988) 602-606
4. Daly T.M., and Long C.A. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J Immunol 155 (1995) 236-243
5. Heppner D.G., Gordon D.M., Gross M., Wellde B., Leitner B., Krzych U., et al. Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes. J Infect Dis 174 (1996) 361-366
6. Ling I.T., Ogun S.A., Momin P., Richards R.L., Garcon N., Cohen J., et al. Immunization against the murine malaria parasite Plasmodium yoelii using recombinant protein with adjuvants developed for clinical use. Vaccine 15 (1997) 1562-1567
7. Pye D., Vandenberg K.L., Dyer S.L., Irving D.O., Goss N.H., Woodrow G.C., et al. Selection of an adjuvant for vaccination with the malaria antigen, MSA-2. Vaccine 15 (1997) 1017-1023
8. Burns Jr. J.M., Dunn P.D., and Russo D.M. Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens. Infect Immun 65 (1997) 3138-3145
9. Ray P., Sahoo N., Singh B., and Kironde F.A.S. Serum antibody Immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens involved in interspecies cross reactive inhibition of parasite growth. Infect Immun 62 (1994) 2354-2361
10. Waters A.P., Thomas A.W., Deans J.A., Mitchell G.H., Hudson D.E., Miller L.H., et al. A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout plasmodium. J Biol Chem 265 (1990) 17974-17979
11. Singleton W.S., Gray M.S., and Brown M.L. A method for adsorbent fractionation of cotton seed oil for experimental intravenous fat emulsions. J Am Oil Chem Soc 42 (1965) 53-56
12. Dutta GP, Pandey A. Selection of multiple drug and antibiotic resistant strains of rodent malaria parasite Plasmodium yoelii nigeriensis. Abstract. Second Asian Congress of Parasitogy, Lucknow, India; 1986. p. 9.
13. Kironde F.A.S., Kumar A., Nayak A.R., and Karaikov J.L. Antibody recognition and isoelectric focusing of antigens of the malaria parasite Plasmodium yoelii. Infect Immun 59 (1991) 3909-3916
14. Amante F.H., and Good M.F. Prolonged Th-1 like response generated by a Plasmodium yoelii specific T-cell clone allows complete clearance of infection in reconstituted mice. Parasite Immunol 19 (1997) 111-126
15. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256 (1981) 1604-1607
16. Smythe J., Coppel R.L., Brown G.V., Kemp D.J., and Anders R.F. Identification of novel integral membrane proteins of Plasmodium falciparum. Proc Natl Acad Sci USA 85 (1988) 5195-5199
17. 4. Nature 227 (1970) 680
18. Knudsen K.A. Proteins transferred to nitrocellulose for use as immunogens. Anal Biochem 147 (1985) 285-288
19. Petri Jr. W.A., and Wagner R.R. Reconstitution into liposomes of the glycoprotein of vesicular stomatitis virus by detergent dialysis. J Biol Chem 254 (1979) 4313-4316
20. Ahmad N., Masood A.K., and Owais M. Fusogenic potential of prokaryotic membrane lipids: implication in vaccine development. Eur J Biochem 268 (2001) 5667-56675
21. Agrewala J.N., Sumit S., Verma R.K., and Mishra G.C. Differential effect of anti-B7.1 anti-M150 antibodies in restricting the delivery off costimulatory signals from B-cells and macrophages. J Immunol 160 (1998) 1067-1077
22. Langhorne J., Quin S.J., and Sanni L.A. Mouse models of blood stage malaria infections: immune responses and cytokines involved in protection and pathology. In: Perlmann P., and Troye-Blomberg M. (Eds). Malaria immunology (2002), Karger, Switzerland 204-228
23. Mohan K., and Stevenson M.M. Acquired immunity to asexual blood stages. In: Sherman I.W. (Ed). Malaria: parasite biology, pathogenesis and protection (1998), American Soc. Microbiol, Washington, DC 467-493
24. Stevenson M.M., and Riley E.M. Innate immunity to malaria. Nat Rev Immunol 4 (2004) 169-180
25. Hodder A., Crewther P., Matthew S.M., Reid G.E., Moritz R.L., Simpson R.J., et al. The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 271 (1996) 2952-29446
26. Dutta S.P., Malhotra, and Chauhan V.S. Sequence analysis of apical membrane antigen (AMA-1) of Plasmodium cyanomolgi bastianelli. Mol Biochem Parasitol 73 (1995) 267-270
27. Marshall V.M., Peterson M.G., Lew A.M., and Kemp D.J. Structure of the apical membrane antigen (AMA-1) of Plasmodium chabaudi. Mol Biochem Parasitol 37 (1989) 281-283
28. Peterson M.G., Nguven-Dinh P., Marshall V.M., Elliott J.F., Collins W.E., Anders R.F., et al. Apical membrane antigen (AMA-1) of Plasmodium fragile. Mol Biochem Parasitol 39 (1990) 279-283
29. Crewther P.E., Mathew M.L.S.W., Flegg R.H., and Anders R.F. Plasmodium falciparum: two antigens of similar size are located in different compartments of the rhoptry. Exp Parasitol 70 (1990) 193-206
30. Peterson M.G., Marshall V.M., Elliott J.F., Collins W.E., Anders R.F., and Kemp D.J. Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol Cell Biol 9 (1989) 3151-3154
31. Narum D.L., and Thomas A.W. Differential localization of the full length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem Parasitol 67 (1994) 59-68
32. Owais M., and Gupta C.M. Liposome mediated cytosolic delivery of macromolecules and its possible use in vaccine development. Eur J Biochem 267 (2000) 3946-3956
33. Ahmad N., Deeba F., Faisal S.M., Khan A., Agrewala J.N., Dwivedi V., et al. Role of fusogenic non-PC liposomes in elicitation of protective immune response against experimental murine salmonellosis. Biochimie 88 (2006) 1391-1400
34. + cytotoxic T-cell response. Vaccine 21 (2003) 2383-2393
35. Sharma S.K., Bhattacharya S., Deba F., Bajpai P., Agrawal A., and Owais M. Escheriosome entrapped soluble blood stage antigens impart protective immunity against less susceptible isolate of Plasmodium yoelii nigeriensis in BALB/c mice. Vaccine 14 (2006) 948-956
36. + T-cell immune response and protects hamsters against visceral leishmaniasis. Vaccine 24 (2006) 1800-1810
37. Agrewala J.N., Owais M., Gupta C.M., and Mishra G.C. Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th-2 cells. Cytokines Mol Ther 2 (1996) 59-65
38. Deans J.A., Knight A.M., Jeans W.C., Waters A.P., Cohen S., and Mitchell G.H. Vaccination of rhesus monkeys with a minor invariant Plasmodium knowlesi 66 kDa merozoite antigen. Parasite Immunol 10 (1988) 535-552
39. Good M.F., Kaslow D.C., and Miller L.H. Pathways and strategies for developing a malaria blood-stage vaccine. Ann Rev Immunol 16 (1998) 57-87
40. Freeman R.R., Trejdosiewicz A.J., and Cross G.A.M. Protective monoclonal antibodies recognizing stage specific merozoite antigens of a rodent malaria parasite. Nature 284 (1980) 366-368
41. Wendy I.W., Charles B.E., and Diane W.T. Antimalarial antibodies of IgG2a isotype modulate parasitaemia in mice infected with P. yoelii. Infect Immun 59 (1991) 3547-3554
42. Altschul S.F., Madden T.L., Schaffer A.A., Zhang Z., Miller W., and Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25 (1997) 3389-3402
43. Gasteiger E., Hoogland C., Gattiker A., Duvaud S., Wilkins M.R., Appel R.D., et al. Protein identification and analysis tools on the ExPASy server. In: Walker J.M. (Ed). The proteomics protocols handbook (2005), Humana Press
44. Hodder A.N., Crewther P.E., and Anders R. Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun 69 (2001) 3286-3294
45. Crewther P.E., Matthew M.L., Flegg R.H., and Anders R.F. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain specific epitopes. Infect Immun 64 (1996) 3310-3317